Back
Nucor Corp. 10K Form
Buy
58
NUE
Nucor Corp.
Last Price:
$179.99
Seasonality Move:
5.52%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | NUE/Nucor Corp. Quarterly |
| 2024-02-27 | 10K | NUE/Nucor Corp. Annual |
| 2023-11-08 | 10Q | NUE/Nucor Corp. Quarterly |
| 2023-08-09 | 10Q | NUE/Nucor Corp. Quarterly |
| 2023-05-10 | 10Q | NUE/Nucor Corp. Quarterly |
| 2023-03-01 | 10K | NUE/Nucor Corp. Annual |
Receive NUE News And Ratings
See the #1 stock for the next 7 days that we like better than NUE
NUE Financial Statistics
Sales & Book Value
| Annual Sales: | $32.5B |
|---|---|
| Cash Flow: | $-3M |
| Price / Cash Flow: | 66.07 |
| Annual Sales: | $90.78 |
| Price / Book: | 1.98 |
Profitability
| EPS (TTM): | 7.53760 |
|---|---|
| Net Income (TTM): | $2B |
| Gross Margin: | $3.9B |
| Return on Equity: | 9.41% |
| Return on Assets: | 5.89% |
Nucor Corp. Earnings Forecast
Key Nucor Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for NUE is 11.93%.
-
The Selling, General & Administrative Expenses for NUE have been equal to 3.75% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 2.89% of Operating Income.
-
The Net Earning history of NUE is 6.27% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 23 years.
Nucor Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Metals & Mining |
| Sector: | Materials |
| Current Symbol: | NUE |
| CUSIP: | 670346 |
| Website: | nucor.com |
Debt
| Debt-to-Equity Ratio: | 0.34 |
|---|---|
| Current Ratio: | 2.94 |
| Quick Ratio: | 1.45 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.94 |
|---|---|
| Forward P/E Ratio: | 13.16 |
NUE Technical Analysis vs Fundamental Analysis
Buy
58
Nucor Corp. (NUE)
is a Buy
Is Nucor Corp. a Buy or a Sell?
-
Nucor Corp. stock is rated a BuyThe current Nucor Corp. [NUE] share price is $180.04. The Score for NUE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.